Rate My Professor Corinne Mirkazemi,

Dr. Corinne Mirkazemi is a Senior Lecturer in Pharmacy Practice in the School of Pharmacy and Pharmacology, College of Health and Medicine, at the University of Tasmania. She holds a Bachelor of Pharmacy (Honours) and a PhD from the University of Tasmania. As a practising community and research pharmacist, she possesses over 10 years of clinical hospital pharmacy practice and teaching experience. Her career at the University of Tasmania encompasses research, teaching, and coordination of units such as CSA321 Clinical Pharmacy Research and CSA212 Safety and Quality in Medication Management.

Dr. Mirkazemi's research specializations focus on clinical pharmacy practice, including pharmacist-led interventions for medication optimization, perioperative medication management, thromboprophylaxis following hip and knee arthroplasty, prophylactic antibiotic dosing and surgical site infections in obese patients, budget impacts of iron infusions, global trends in ESBL-producing Escherichia coli intestinal carriage, nutrition education for practising pharmacists, and associations between maternal antibiotic exposure and depressive symptoms. She has produced 29 peer-reviewed publications, accumulating 378 citations. Key works include "Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a systematic review and meta-analysis" (2022), "Antibiotic use and the development of depression: A systematic review" (2023), "The effect of pharmacist-led interventions on the appropriateness and clinical outcomes of anticoagulant therapy: a systematic review and meta-analysis" (2024), "Prophylactic Cefazolin Dosing and Surgical Site Infections: Does the Dose Matter in Obese Patients?" (2019), "Comparing Australian orthopaedic surgeons’ reported use of thromboprophylaxis following arthroplasty in 2012 and 2017" (2019), "A budget impact analysis of iron polymaltose and ferric carboxymaltose infusions" (2021), and "Risk of venous thromboembolism, use of enoxaparin and clinical outcomes in obese patients undergoing laparoscopic adjustable gastric band surgery" (2020). Her contributions inform evidence-based practices in hospital and community pharmacy settings, emphasising improved patient outcomes through optimised pharmacotherapy.